title: Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification.
abstract: One main pathophysiological mechanism underlying the increased risk for uric acid nephrolithiasis in humans with the metabolic syndrome is the excretion of unduly acidic urine, in part because of reduced excretion of the main urinary buffer, ammonium. The Zucker diabetic fatty (ZDF) rat, an established rodent model of the metabolic syndrome, has similar urinary abnormalities, attributed in part to lower expression and activity of the principal mediator of proximal tubule ammonium excretion, brush-border membrane Na+/H+ exchanger 3 (NHE3). These defects are associated with renal tubular steatosis in ZDF rats, but the causal relationship between renal steatosis and defective urinary acidification has not been investigated in vivo. We hypothesized that reduction of renal steatosis would commensurately normalize urinary acidification parameters. We treated ZDF rats with thiazolidinediones to reduce nonadipose tissue steatosis. Four weeks of treatment reduced renal triglyceride accumulation and restored urinary acidification parameters in ZDF rats to levels comparable to their lean littermates; urinary acidification was not affected by treatment in lean rats. To further document the direct effects of fat, we showed that functional abnormalities induced by fat loading in a cell culture model of proximal tubule steatosis and lipotoxicity can be reversed by fat removal but not by thiazolidinediones alone. Together, these findings support the causative role of renal steatosis in the pathogenesis of urinary acidification defects, demonstrate reversibility upon lipid removal, and highlight a potential therapeutic strategy for renal abnormalities in the metabolic syndrome.
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8856, USA.
authors.forename: I Alexandru
authors.initials: IA
authors.lastname: Bobulescu
authors.forename: Michele
authors.initials: M
authors.lastname: Dubree
authors.forename: Jianning
authors.initials: J
authors.lastname: Zhang
authors.forename: Paul
authors.initials: P
authors.lastname: McLeroy
authors.forename: Orson W
authors.initials: OW
authors.lastname: Moe
mesh_terms: D000143:Acids / Q000652:urine*; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D002478:Cells, Cultured; D005230:Fatty Acids, Nonesterified / Q000097:blood; D007668:Kidney / Q000378:metabolism*; D007687:Kidney Tubules, Proximal / Q000378:metabolism*; D008871:Microvilli / Q000378:metabolism; D009893:Opossums; D047495:PPAR gamma / Q000819:agonists; D051381:Rats; D011924:Rats, Zucker; D000074083:Sodium-Hydrogen Exchanger 3; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism*; D045162:Thiazolidinediones / Q000494:pharmacology; D014280:Triglycerides / Q000378:metabolism*
chemical_list: D000143:Acids; D005230:Fatty Acids, Nonesterified; D047495:PPAR gamma; C000613385:SLC9A3 protein, human; C000613387:Slc9a3 protein, rat; D000074083:Sodium-Hydrogen Exchanger 3; D017923:Sodium-Hydrogen Exchangers; D045162:Thiazolidinediones; D014280:Triglycerides
references.citation: J Lipid Res. 2005 Jun;46(6):1295-302
references.pmid: 15772429
references.citation: J Am Soc Nephrol. 2006 Jul;17(7):2026-33
references.pmid: 16775030
references.citation: Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E216-21
references.pmid: 15367397
references.citation: J Biol Chem. 1957 May;226(1):497-509
references.pmid: 13428781
references.citation: J Hum Hypertens. 2003 Jan;17(1):7-12
references.pmid: 12571611
references.citation: N Engl J Med. 2004 Sep 9;351(11):1106-18
references.pmid: 15356308
references.citation: Pflugers Arch. 2009 May;458(1):5-21
references.pmid: 18853182
references.citation: Kidney Int. 2004 Apr;65(4):1422-5
references.pmid: 15086484
references.citation: J Am Soc Nephrol. 1999 Nov;10(11):2412-25
references.pmid: 10541303
references.citation: Am J Kidney Dis. 2006 Dec;48(6):905-15
references.pmid: 17162145
references.citation: J Clin Invest. 1996 Nov 15;98(10):2381-7
references.pmid: 8941657
references.citation: J Clin Invest. 1988 Jan;81(1):159-64
references.pmid: 3121674
references.citation: Annu Rev Physiol. 2005;67:573-94
references.pmid: 15709971
references.citation: Am J Physiol Renal Physiol. 2005 Oct;289(4):F685-91
references.pmid: 15942046
references.citation: Am J Physiol. 1997 Oct;273(4):E708-13
references.pmid: 9357799
references.citation: Annu Rev Med. 2002;53:319-36
references.pmid: 11818477
references.citation: Am J Physiol. 1981 Nov;241(5):C220-6
references.pmid: 6272583
references.citation: Drug Metab Dispos. 2000 Jul;28(7):772-80
references.pmid: 10859151
references.citation: Kidney Int. 2006 Feb;69(3):440-9
references.pmid: 16514429
references.citation: Metabolism. 1967 Feb;16(2):176-88
references.pmid: 6018961
references.citation: Diabetes. 1995 Aug;44(8):863-70
references.pmid: 7621989
references.citation: Proc Soc Exp Biol Med. 1983 May;173(1):68-75
references.pmid: 6344096
references.citation: Kidney Int. 2006 Nov;70(9):1560-6
references.pmid: 16955100
references.citation: Am J Physiol Renal Physiol. 2005 Aug;289(2):F442-50
references.pmid: 15814531
references.citation: Diabetes. 1988 Aug;37(8):1020-4
references.pmid: 3292322
references.citation: Kidney Int. 2007 Dec;72(11):1367-73
references.pmid: 17805239
references.citation: Kidney Int. 2007 Mar;71(6):504-13
references.pmid: 17228368
references.citation: Am J Nephrol. 2006;26(3):245-57
references.pmid: 16757903
references.citation: J Am Soc Nephrol. 2004 Nov;15(11):2775-91
references.pmid: 15504931
references.citation: J Clin Invest. 1991 Nov;88(5):1703-8
references.pmid: 1658050
references.citation: J Am Soc Nephrol. 1991 May;1(11):1193-203
references.pmid: 1932632
references.citation: Am J Physiol. 1989 Apr;256(4 Pt 2):F672-9
references.pmid: 2539748
references.citation: Am J Physiol Renal Physiol. 2008 Jun;294(6):F1315-22
references.pmid: 18417539
references.citation: N Engl J Med. 2006 Nov 30;355(22):2297-307
references.pmid: 17135584
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Mar 5;801(2):265-72
references.pmid: 14751795
references.citation: Am J Kidney Dis. 1989 Oct;14(4):258-61
references.pmid: 2679054
references.citation: J Clin Invest. 1962 Mar;41:537-42
references.pmid: 14036165
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1784-9
references.pmid: 10677535
references.citation: J Clin Invest. 2000 Jul;106(2):171-6
references.pmid: 10903330
references.citation: Kidney Int. 2002 Sep;62(3):971-9
references.pmid: 12164880
references.citation: Diabetes Obes Metab. 2003 Jul;5(4):234-43
references.pmid: 12795656
references.citation: Am J Physiol Cell Physiol. 2004 Jul;287(1):C64-72
references.pmid: 14973148
references.citation: Am J Physiol Endocrinol Metab. 2002 Oct;283(4):E729-37
references.pmid: 12217890
references.citation: Clin J Am Soc Nephrol. 2007 Sep;2(5):883-8
references.pmid: 17702734
references.citation: Am J Physiol Renal Physiol. 2008 Oct;295(4):F1071-81
references.pmid: 18667486
references.citation: Clin J Am Soc Nephrol. 2007 May;2(3):550-62
references.pmid: 17699463
references.citation: Kidney Int. 2001 Aug;60(2):757-61
references.pmid: 11473659
references.citation: Curr Opin Lipidol. 2003 Jun;14(3):281-7
references.pmid: 12840659
references.citation: FASEB J. 2001 Feb;15(2):312-21
references.pmid: 11156947
references.citation: J Am Soc Nephrol. 2006 May;17(5):1422-8
references.pmid: 16597681
references.citation: J Nutr Sci Vitaminol (Tokyo). 1992 Oct;38(5):517-21
references.pmid: 1294711
references.citation: Am J Physiol. 1995 Jun;268(6 Pt 2):F1177-84
references.pmid: 7611458
references.citation: Am J Physiol Endocrinol Metab. 2005 May;288(5):E930-4
references.pmid: 15632102
references.citation: Diabetes. 2004 Aug;53(8):2169-76
references.pmid: 15277403
references.citation: Am J Physiol. 1982 Jun;242(6):F733-9
references.pmid: 6283903